Dulac Edward J III - Insider Non-Derivative Transactions at Intellia Therapeutics, Inc. (NTLA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 22, 2024, Dulac Edward J III's relationship to Intellia Therapeutics, Inc. (NTLA) is Officer (EVP, Chief Financial Officer), and currently has 66,324 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NTLA insiders.
Data Source: SEC.
Dulac Edward J III - Insider Non-Derivative Transactions at NTLA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 23, 2024 | Acquisition -- (Common Stock) | 66324 | 0 | 66324 |